China Carnitine Market Holds Firm in Early December After 6% Price Rise in November

China Carnitine Market Holds Firm in Early December After 6% Price Rise in November

Borges 22-Dec-2025

China’s Carnitine market took off in November 2025, with prices bouncing up month-on-month and staying firm right through into the first week of December. Behind the scenes, higher production costs, factory production rates being kept tight, and a balanced flow of supply all played their part in keeping the price going up. Producers were able to hold out for higher prices simply because stock levels weren’t getting out of hand, and there wasn’t the kind of demand to push them to clear stock that might have been expected. In addition to this, steady sales from the nutrition, beverage, and feed sectors, along with a consistent stream of exports to key markets, helped maintain a positive outlook. Going into early December, prices levelled out a bit at a higher level; rather than buyers rushing out to buy, that kept the higher price maintained in early December. However, at the end of the year, buyer confidence is starting to waver slightly; they're becoming risk-averse and more cautious, focusing on maintaining a stable stock level rather than increasing purchases. Market experts now think the recent strength is going to start to ease, and with demand softening and some sellers just looking to get rid of stock, they expect prices to drop off a bit later in the coming weeks of December.

Selenis has effectively manufactured recycled PET chips using terephthalic acid sourced from Circ®, a textile-to-textile recycler based in Virginia. The chip production took place through a series of batches at Selenis' pilot plant in San-Giorgio, Italy. By utilizing inputs recovered from polycotton textile waste, Selenis has created high-quality PET chip, which has been further processed into DTY yarn. This yarn will play a crucial role in product development as Circ prepares for additional capsule launches. Selenis is leveraging the success of this initial collaboration phase and is committed to advancing towards an offtake partnership to support Circ's inaugural industrial facility. Eduardo Santos, Head of Corporate Strategy at Selenis, remarked that the monomer synthesis showed a performance comparable to virgin terephthalic acid. He expressed optimism about the consistent quality of Circ's monomer output and anticipated future commercial success. Santos pointed out that the Circ partnership complements Selenis's existing mission and goals for a more sustainable textile industry. He further stated their anticipation of expanding upon this collaboration and providing support for Circ's forthcoming commercial production trials.
Tags:

Carnitine

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.